DALLAS, TX -- February 24, 2026 -- Electro Optics Systems Holdings Ltd (ASX: EOS): Stonegate Capital Partners Updates Coverage on Electro Optics Systems Holdings Ltd (ASX: EOS). EOS reported FY25 revenue, gross margin, and EBITDA of $126.3M, 63%, and $(24.4M), respectively, with the revenue decline driven by the EM Solutions divestment and order timing shifting later in FY25, expected to convert into FY26. EOS ended the year with $106.9M of cash and strong order momentum with 18 contracts signed worth ~$420M and an unconditional order book of ~$459M (ex-Korea), supporting a higher delivery cadence through FY26–FY28 as mix shifts toward higher-value RWS/counter-drone/HELW and manufacturing scales.
Continued Diversification Through Acquisition: The transaction of MARSS, announced 12 January 2026, comprises US$36M (~A$54M) of upfront cash consideration plus a performance-linked earnout of up to €100M, contingent on new third-party MARSS order intake during the earnout period. Importantly, management noted that typical MARSS bid sizes are €20–30M, with select opportunities in the €50–100M range and emphasized that MARSS’ pipeline is not currently reflected in EOS’ disclosed pipeline/order book metrics creating incremental upside potential. EOS has added interceptor drones to its layered counter-drone toolkit alongside RWS and HELW. NiDAR C2, acquired through MARSS, integrates detection and effector tasking, supporting EOS’s shift toward an end-to-end solution rather than standalone hardware.
Significant HELW Contract: EOS reiterated that it was the first company to sign a 100kW HELW export contract, citing the Dutch government award valued at ~€71M (~A$125M). To support commercialization and scale, EOS opened a serial HELW production facility in Singapore on 6 February 2026, a 20,000 sq. ft. site with initial capacity of ~20 systems per year and expansion potential to ~40 systems per year. Execution on the Netherlands program is progressing, with initial design approval milestones completed in 4Q25 and revenue/progress cash milestones already received in 2025, which EOS expects to continue recognizing across 2026–2028. Management also noted ongoing discussions with the customer around scope expansion, accelerated delivery timing, and potential follow-on orders.
Growth Outlook: EOS is executing a medium-term plan that is two parts organic and one part inorganic, prioritizing counter-drone/RWS over the next 1-3 years and scaling HELW over 2-5 years as export programs move from first deliveries to repeatable production. With the Dutch 100kW HELW deal underway and scope/follow-on discussions ongoing, management expects growth to sharpen into focus, supported by strong European rearmament tailwinds.
Strong Backlog: EOS exited FY25 with strong visibility, signing 18 contracts (~A$420m) and building an unconditional order book of ~A$459m (excluding the US$80m conditional Korea laser) of which 40% to 50% will be targeted by management in FY26. Management expects monetization to accelerate through FY26-FY28, with upside from MARSS pipeline conversion that is not yet reflected in EOS’ disclosed pipeline metrics.
Valuation: We use both a DCF Analysis and Comparable Analysis to inform our valuation of EOS. Our DCF analysis arrives at a valuation range of AUD$7.10 to AUD$8.36 with a midpoint of AUD$7.67. For the Comparable Analysis we arrive at a valuation range of AUD$7.45 to AUD$8.14 with a midpoint of AUD$7.79.
Stonegate Capital Partners is a leading capital markets advisory firm providing investor relations, equity research, and institutional investor outreach services for public companies. Our affiliate, Stonegate Capital Markets (member FINRA) provides a full spectrum of investment banking services for public and private companies.
